{"name":"Neutrolis","slug":"neutrolis","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBXM013M0UyOGpLLUdHekI0dHpkWThhTjlFRXRnajRtWXJtTkNkWFBLbmd5cHFrV3hhVTJlbXlUSVJJV01CTHplZ24tbVJEbGM5QndN?oc=5","date":"2025-04-15","type":"pipeline","source":"FirstWord Pharma","summary":"Sanofi tempers its OX40 expectations in asthma after mid-stage miss - FirstWord Pharma","headline":"Sanofi tempers its OX40 expectations in asthma after mid-stage miss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxORHdISE1XTnRhbGxRcDVlVDhFWmQ2UkVISml2X01pZlhSSGEzaEEzNkxOUE5XenNhMXVkZWxVS2J1Um1FOExScjhHbkRndzdBVW9yenZsRVl3eFVRb1VCTzNxWm4zYUNMRE1oeGxIbGRVMDlWcXdwcUJ1NmZiRnNKZi1oUGNxNGQ0ZXdCN2I2dmpMdw?oc=5","date":"2024-12-20","type":"regulatory","source":"Fierce Biotech","summary":"FDA's principal deputy to depart agency—Chutes & Ladders - Fierce Biotech","headline":"FDA's principal deputy to depart agency—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPYXFwZ3BwV3JmVkVSakFUUnpaQVhFcFdseXlEY3RIUUdTMFVlaC1HR0RuQkhYSDYzQW1UcGU3R2pHOGZOUHhKUjdtQ3FPQzcwY1VVLWJPOUFjZUdkS3FVSExlRUJmdlNaZHJTNDB1bktlMHVwQ04xdnoxQTI5WWg2MnJ1UmZ5NGUxMnVqbS13dzdKdUZ5RlZNS2xoWVVRWmpPRTBpbUZLMF9SVVFXYWRJeXlZYkRqd2NBXzV0OE9wU1p4YXM1enVtbl9zRElqQjhpX0swUldGcy0xTlRXbU5lbG9HeXhreEg3elllYW1Hc2RSY3pTU3ZWWEVIYWE1NV90Uld3X05vbXQ?oc=5","date":"2022-07-26","type":"pipeline","source":"PR Newswire","summary":"New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsight - PR Newswire","headline":"New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9LSlBac3IzNnoweGtaR21UdVRpMHlQLVlRWjdCN1JzbEtpRC1sckdRYkZVMWRUazhrYVBXSDVmcDl5RTRYWnJxN0UyWkJlTHRUNDZiVVJsMDhGamdXcE9MNmx3WXdDSGxteXpZaU1YRTU1aVEzZWh2aEJnS3VJWE0?oc=5","date":"2021-01-15","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Biosimilars of pegfilgrastim - Generics and Biosimilars Initiative","headline":"Biosimilars of pegfilgrastim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOeHlGVENsdzVOcmpwVTZEOV9RLUtROGRzbXdTUERCZ0hWVkZVUFZpUElKaEw0R0hiLTBNNW1UcFdwNTdyWV9kdWdoMDFlY1hPRm9mOWIySDh2SzFYdGE0SnB6RXdsWTIwSUw0YjVObUNBOVdrMFgzSjF5bmlldTQyUHo2MlU4TGJMYk9xYkJnMUY2MFNscDlaT0lR?oc=5","date":"2020-03-05","type":"pipeline","source":"Science | AAAS","summary":"New drugs aim to disarm the immune system's ‘atomic bomb' cells - Science | AAAS","headline":"New drugs aim to disarm the immune system's ‘atomic bomb' cells - Science | AAAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxObTlhMS1CSmptVXl3ZXZKVXNKUmhySlpRaWI1T3JLRjNpblNZbXB6V3RpbzRRcUIyMjJJMWpodm5kdzBVX21EZ1ozVTFWTGhWQ2UwN1pOUW1EMXFfcDdocGZ2enBLOEw3OFFBZWtHVHd6QU1HREliYUhzdGlsbDA2VGR2U3pkbTJvcnk5RV9NcjZoc3djczlqclpHSXN6Z25hT0oxQlJzUjVsQzVJbzZVcEc5ZGdzaF9UM1lTWXVheGs?oc=5","date":"2019-11-07","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Nanoparticles and Cancer Drug Combined to Target Inflammatory Neutrophils - Genetic Engineering and Biotechnology News","headline":"Nanoparticles and Cancer Drug Combined to Target Inflammatory Neutrophils","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1yQm1meW1pNjY5SkRjSkRSaVNpUUpsZWRDbnBDMHk2dE82c0JicEpBeWlYblRjN3kyRERXclg4NEdlVXdTOTBHeHR5OUtWblZkSk1qbGpWM0E5X09fWC1BZjQzM2MzS1h6bkY4M2lOSQ?oc=5","date":"2019-10-02","type":"pipeline","source":"statnews.com","summary":"They got Pfizer’s ‘Golden Ticket.’ Did it live up to the hype? - statnews.com","headline":"They got Pfizer’s ‘Golden Ticket.’ Did it live up to the hype?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}